A detailed history of Pictet Asset Management Sa transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 102,316 shares of DNA stock, worth $967,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,316
Previous 102,316 -0.0%
Holding current value
$967,909
Previous $136,000 39.71%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$1.63 - $3.52 $100,756 - $217,585
61,814 Added 152.62%
102,316 $173,000
Q2 2022

Aug 09, 2022

BUY
$2.2 - $4.2 $89,104 - $170,108
40,502 New
40,502 $96,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.